Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bakris

Showing results (141-150 of 991) with videos related to

Pageof 100
Sort By:
Hypertension (Dallas, Tex. : 1979)|August 26, 2015
New potassium binders for the treatment of hyperkalemia: current data and opportunities for the futureBertram Pitt, George L Bakris
Seminars in Nephrology|July 14, 2014
Prediction and management of hyperkalemia across the spectrum of chronic kidney diseaseIvana Lazich, George L Bakris
Current Opinion in Nephrology and Hypertension|August 4, 2017
Nonsteroidal mineralocorticoid antagonists in diabetic kidney diseaseFarheen K Dojki, George Bakris
Clinical Journal of the American Society of Nephrology : CJASN|November 5, 2017
Consequences of Overinterpreting Serum Creatinine Increases when Achieving BP Reduction: Balancing Risks and Benefits of BP Reduction in HypertensionHala Yamout, George L Bakris
Journal of the American Society of Hypertension : JASH|March 26, 2013
Recognition and management of masked hypertension: a review and novel approachYuichiro Yano, George L Bakris
American Journal of Nephrology|September 1, 2016
New Onset Hypertension Linked to Generic Cyclosporine Substitution in Post-Renal Transplant PatientOmar Al Dhaybi, George Bakris
Kidney International. Supplement|January 4, 1998
Angiotensin II receptor blockade and progression of nondiabetic-mediated renal diseaseN Tarif, G L Bakris
Blood Purification|January 15, 2016
Management of Hypertension in Diabetic Nephropathy: How Low Should We Go?Hillel Sternlicht, George L Bakris
Current Diabetes Reports|February 17, 2016
Has RAAS Blockade Reached Its Limits in the Treatment of Diabetic Nephropathy?Collen Majewski, George L Bakris
Cells|August 11, 2023
Slowing the Progression of Diabetic Kidney DiseaseOlivia Blazek, George L Bakris
Pageof 100

Showing results (141-150 of 991) with videos related to

Sort By:
Pageof 100
Hypertension (Dallas, Tex. : 1979)|August 26, 2015
New potassium binders for the treatment of hyperkalemia: current data and opportunities for the futureBertram Pitt, George L Bakris
Seminars in Nephrology|July 14, 2014
Prediction and management of hyperkalemia across the spectrum of chronic kidney diseaseIvana Lazich, George L Bakris
Current Opinion in Nephrology and Hypertension|August 4, 2017
Nonsteroidal mineralocorticoid antagonists in diabetic kidney diseaseFarheen K Dojki, George Bakris
Clinical Journal of the American Society of Nephrology : CJASN|November 5, 2017
Consequences of Overinterpreting Serum Creatinine Increases when Achieving BP Reduction: Balancing Risks and Benefits of BP Reduction in HypertensionHala Yamout, George L Bakris
Journal of the American Society of Hypertension : JASH|March 26, 2013
Recognition and management of masked hypertension: a review and novel approachYuichiro Yano, George L Bakris
American Journal of Nephrology|September 1, 2016
New Onset Hypertension Linked to Generic Cyclosporine Substitution in Post-Renal Transplant PatientOmar Al Dhaybi, George Bakris
Kidney International. Supplement|January 4, 1998
Angiotensin II receptor blockade and progression of nondiabetic-mediated renal diseaseN Tarif, G L Bakris
Blood Purification|January 15, 2016
Management of Hypertension in Diabetic Nephropathy: How Low Should We Go?Hillel Sternlicht, George L Bakris
Current Diabetes Reports|February 17, 2016
Has RAAS Blockade Reached Its Limits in the Treatment of Diabetic Nephropathy?Collen Majewski, George L Bakris
Cells|August 11, 2023
Slowing the Progression of Diabetic Kidney DiseaseOlivia Blazek, George L Bakris
Pageof 100